Stock market today: Stocks fall as investors rotate out of tech into Jackson Hole
ATLANTA - Guardian Pharmacy Services, Inc. (NYSE:GRDN), a major provider of pharmacy services for long-term care facilities with a market capitalization of $1.68 billion, announced today a proposed underwritten public offering of 7.5 million shares of Class A common stock. The company’s stock has shown remarkable strength, trading near its 52-week high of $26.91 and delivering a 65.75% return over the past year. According to InvestingPro analysis, the company currently appears overvalued relative to its Fair Value. The offering includes over 6 million shares from certain selling stockholders, with the company offering approximately 1.44 million new shares in a non-dilutive transaction.
The company will use the net proceeds from its newly issued shares to repurchase an equivalent number of shares at the public offering price, less the underwriting discount, in what is termed a "Synthetic Secondary" transaction. This move will keep the total number of outstanding shares unchanged post-offering. InvestingPro data reveals that Guardian operates with a moderate level of debt, maintaining a healthy debt-to-equity ratio of 0.18.
Raymond James is leading the offering as the bookrunning manager, with Stephens Inc. and Truist Securities also serving as joint bookrunning managers. The offering is contingent upon the effectiveness of a registration statement filed with the U.S. Securities and Exchange Commission (SEC), which is currently pending.
Guardian Pharmacy Services, which as of March 31, 2025, serves approximately 189,000 residents across 7,000 long-term care facilities in 38 states, is known for its suite of technology-enabled services that aim to improve clinical outcomes and reduce healthcare costs. The company has demonstrated strong growth, with revenue increasing by 19.54% in the last twelve months to $1.28 billion. Discover more detailed insights and 8 additional ProTips with a subscription to InvestingPro.
The proposed offering is only available through a prospectus, details of which can be obtained from Raymond James & Associates, Inc. The company has cautioned that this announcement contains forward-looking statements and that actual events could differ materially.
This news is based on a press release statement from Guardian Pharmacy Services, Inc.
In other recent news, Guardian Pharmacy Services reported a 20% year-over-year increase in revenue for the first quarter of 2025, reaching $329.3 million. The company’s earnings per share (EPS) for the quarter was $0.15, and it anticipates full-year revenue to fall within the upper half of its $1.33 billion to $1.35 billion guidance range. In a strategic move to expand its operations, Guardian Pharmacy Services acquired Senior Care Pharmacy in Wichita, Kansas, enhancing its service capabilities in the region. The acquisition aligns with Guardian’s growth strategy, which includes both organic expansion and acquisitions. Additionally, Guardian Pharmacy Services entered into stock purchase agreements to repurchase up to 1,457,365 shares of its Class A common stock. This repurchase is part of a private transaction funded by an underwritten public offering of Class A stock. Furthermore, Guardian Pharmacy Services continues to focus on acquisitions and the integration of new pharmacies, with plans to launch new locations in cities such as Columbus and Oklahoma City. Analysts have noted the company’s ongoing commitment to sustainable growth, with Truist Securities observing a robust acquisition pipeline despite economic uncertainties.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.